Giles Best

Giles Best is a Senior Research Fellow in Flow Cytometry at the College of Medicine and Public Health, Flinders University. He manages the Flow Cytometry facility, collaborating with researchers locally and interstate to design and analyze flow cytometry assays. His work contributes to cancer research, particularly in leukemia, lymphoma, and tumor microenvironment studies.

Education:

• Ph.D. in AMPK regulation of CFTR in Cystic Fibrosis, University of Dundee (2003)

Research Interests: Giles Best specializes in the pathobiology of hematological malignancies, including chronic lymphocytic leukaemia (CLL), multiple myeloma, and acute myeloid leukaemia (AML), with a focus on tumor microenvironment interactions. His work also extends to biomaterials, ferroptosis in cancer therapy, and epidemiological studies of multiple primary cancers.

Scientific Contributions: His recent research explores biomaterial-mediated immune modulation, metabolic reprogramming in cancer progression, and novel therapies for multiple myeloma. These studies align with broader themes in oncology and translational medicine.

Labs and Collaborations: Giles Best is affiliated with the Multiple Myeloma Translational Research Laboratory and the Flinders Health and Medical Research Institute, where he contributes to interdisciplinary collaborations.